Antimicrobial resistance (AMR) is one of the most important challenges in the world, with bacteria evolving faster than new drugs. The discovery of lariocidin, an antibiotic derived from Paenibacillus, offers new hope against resistant bacteria. Lasso peptides, including lariocidin, are a promising therapeutic solution due to their stability and antimicrobial activity.